An mRNA vaccine for avian influenza, developed by pharma company Moderna, has begun Phase 3 human trials. Building on the ...

A groundbreaking human trial has begun that could transform life for people with spinal cord injuries. The project, developed over three decades, uses a unique cell-based approach that scientists hope ...

Neuralink’s first brain implant in a human patient took place in January 2024, but the details of what the company’s clinical trial actually requires of participants, regulators, and the company ...

Following successful small-animal trials that confirmed bioequivalence, BioNxt is now taking the final preclinical step to prepare its sublingual Cladribine formulation for human testing. The upcoming ...

Despite how it sounds, a xenotransplant isn't something from the latest Alien movie. It's an increasingly credible science: the transplantation of animal organs into humans. The field took one of its ...

PETACH TIKVAH, Israel, March 23, 2026 /PRNewswire/ -- Interna Therapeutics, a clinical-stage biopharmaceutical company announced today that it has signed an agreement with the University of Oxford to ...

The combination of placenta-derived stem cells (PMSCs) with standard in utero repair for severe spina bifida appears feasible and safe, with no cell-related adverse events observed at birth, a ...

Add Yahoo as a preferred source to see more of our stories on Google. A world-first trial of nasal cell therapy offers new hope for spinal cord repair and independence after injury. (CREDIT: ...